Aethlon Medical, Inc. (NASDAQ:AEMD) – Equities research analysts at Zacks Investment Research lifted their FY2018 earnings estimates for Aethlon Medical in a research note issued on Wednesday. Zacks Investment Research analyst B. Marckx now expects that the medical equipment provider will earn ($0.56) per share for the year, up from their previous estimate of ($0.57).
Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported ($0.14) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.16) by $0.02.
Separately, ValuEngine downgraded shares of Aethlon Medical from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 11th.
Shares of Aethlon Medical (NASDAQ AEMD) traded up $0.03 on Monday, reaching $0.92. 156,700 shares of the company were exchanged, compared to its average volume of 198,812. Aethlon Medical has a 52-week low of $0.79 and a 52-week high of $5.17.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.